Immunogenicity and Safety of BNT162b2 Homologous Booster Vaccination in People Living with HIV under Effective cART

Immunogenicity and Safety of BNT162b2 Homologous Booster Vaccination in People Living with HIV under Effective cART

Data on COVID-19 boosting vaccination in people living with HIV (PLWH) are scant. We investigated the immunogenicity and safety of the BNT162b2 homologous boosting vaccination. Anti-SARS-CoV-2 spike antibodies (LIAISON<sup>®</sup> SARS-CoV-2 S1/S2 IgG test, DiaSorin<sup>®</sup&g...

Full description

Bibliographic Details
Main Authors: Laura Gianserra, Maria Gabriella Donà, Eugenia Giuliani, Christof Stingone, Martina Pontone, Anna Rita Buonomini, Massimo Giuliani, Fulvia Pimpinelli, Aldo Morrone, Alessandra Latini
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Vaccines
Subjects:
PLWH
booster
vaccine
COVID-19
SARS-CoV-2
humoral response
Online Access:https://www.mdpi.com/2076-393X/10/8/1243

Internet

https://www.mdpi.com/2076-393X/10/8/1243

Similar Items